Cambria Cannabis ETF (TOKE)
| Assets | $15.93M |
| Expense Ratio | 0.43% |
| PE Ratio | 13.62 |
| Shares Out | 2.85M |
| Dividend (ttm) | $0.25 |
| Dividend Yield | 4.59% |
| Ex-Dividend Date | Sep 20, 2024 |
| Payout Ratio | 62.25% |
| 1-Year Return | -0.58% |
| Volume | 8,079 |
| Open | 5.50 |
| Previous Close | 5.50 |
| Day's Range | 5.46 - 5.58 |
| 52-Week Low | 5.13 |
| 52-Week High | 7.47 |
| Beta | 1.13 |
| Holdings | 29 |
| Inception Date | Jul 25, 2019 |
About TOKE
Fund Home PageThe Cambria Cannabis ETF (TOKE) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed portfolio of globally-listed companies related to cannabis and hemp. TOKE was launched on Jul 25, 2019 and is issued by Cambria.
Top 10 Holdings
99.35% of assets| Name | Symbol | Weight |
|---|---|---|
| DEPOSITS WITH BROKER FOR SHORT POSITIONS | n/a | 38.71% |
| Treasury Obligations Fund | FXFXX | 10.25% |
| GROWN ROGUE INTL INC COM SWAP | n/a | 10.18% |
| GLASS HOUSE BRANDS INC SWAP | n/a | 8.90% |
| GREEN THUMB INDUSTRIES INC SWAP | n/a | 6.10% |
| Turning Point Brands, Inc. | TPB | 5.83% |
| Philip Morris International Inc. | PM | 5.33% |
| SNDL Inc. | SNDL | 5.01% |
| Vireo Growth | n/a | 4.59% |
| Altria Group, Inc. | MO | 4.47% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 20, 2024 | $0.082 | Sep 30, 2024 |
| Jun 21, 2024 | $0.052 | Jul 1, 2024 |
| Mar 21, 2024 | $0.063 | Apr 1, 2024 |
| Dec 14, 2023 | $0.054 | Dec 26, 2023 |
| Sep 21, 2023 | $0.061 | Oct 2, 2023 |
| Jun 22, 2023 | $0.053 | Jul 3, 2023 |
News
Road to Full Cannabis Legalization in the U.S.
Morgan Paxhia discusses the latest trends in the cannabis space. He talks about the road to full cannabis legalization in the U.S. He then goes over the best positioned cannabis stocks.
New Year, No Fear
New years are a time for reflection, especially those that follow tough years filled with challenging lessons. Hopium and corruption (or its close relative, greed) are thriving in these volatile days.
Cannabis REITs: Too Cheap To Get High
The previously high-flying cannabis REITs have been slammed this year on concerns over rent payment from their cannabis cultivator tenants, which have been struggling amid a plunge in wholesale cannab...
Cannabis REITs: Weeding Out The Weak
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financia...
Scotts Miracle-Gro Down 10% On Profit Warning
The stock is a holding in 119 ETFs, with cannabis funds offering the most exposure.
5 developments that cannabis investors did not expect in 2021
2021 has been an interesting year for cannabis investors with lots of positive and negative news. According to New Cannabis Ventures, following were the five developments that cannabis investors hadn'...
Marijuana ETFs Blaze Higher
Cannabis-related ETFs are moving higher on news of a Republican-backed proposal for legalization.
Julian Lin's Highest Conviction Idea (Ever)? Cannabis. (Podcast Transcript)
Julian Lin has a new cannabis focused marketplace service, Cannabis Growth Portfolio. We discuss his thoughts on EBITDA, ETFs using total return swaps to own US MSOs, rebalancing away from Canadian op...
Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast Transcript)
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronti...
Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronti...
Unpacking The Cannabis Industry (Podcast Transcript)
George Jage discusses building out a nascent cannabis industry with trade shows and business media. SAFE banking coming? The unfortunate influence of outside money. Shifting to the CPG industry. Unloc...
Is TOKE A Buy? Evaluating The Cambria Cannabis ETF
TOKE is an ETF run by Meb Faber focusing on the cannabis industry. TOKE boasts the lowest expense ratio among cannabis ETFs.
